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2’-Phosphodiesterase from NIH 3T3 cells was purified about 530-fold. Treatment of the cell lysate with the 
CAMP-dependent protein kinase causing the 2’-phosphodiesterase inhibition did not result in phosphoryla- 
tion of the enzyme itself. The kinase was found to phosphorylate a specific 18-kDa protein, the phosphory- 
lated form of this protein being the inhibitor of 2’-phosphodiesterase. 
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1. INTRODUCTION 2. METHODS 
2 ’ -Phosphodiesterase (2 ’ -PDE), the enzyme 
which hydrolyzes 2 ’ ,5 ’ -oligoadenylates (2 ’ ,5 ’ -oli- 
go(A)) to ATP and AMP, is involved in the regula- 
tion of biological processes associated with varia- 
tions of the intracellular 2’ ,5’-ohgo level in- 
cluding interferon action and alterations in the 
proliferative status of cells [l]. 
2.1. Ceil culture 
NIH 3T3 cells were cultivated in the mixture of 
media Eagle’s: 199 (1: 1) containing 10% calf 
serum (Serva, FRG). Rapidly growing cells (224 h 
before confluence) were used for homogenate 
preparation. 
We have previously shown that 2 ’ -PDE activity 
in the NIH 3T3 cells decreases ignificantly as a 
result of the elevation of the intracellular CAMP 
level. The treatment of the cell lysates with the 
homogeneous preparation of the catalytic subunit 
of the CAMP-dependent protein kinase (in the 
presence of ATP) causes the inhibition of 2 ’ -PDE 
activity as well [2]. 
2.2. Treatment of the cell homogenate with 
protein kinase 
The present results show that the inhibition of 
2’ -PDE by CAMP-dependent protein kinase in- 
volves a specific l&kDa protein inhibitor of 
2’ -PDE. Phosphorylation of this protein in cell 
lysate results in the enhancement of its inhibitory 
activity. It is suggested that the previously de- 
scribed CAMP-induced decrease in 2 ’ -PDE activity 
in NIH 3T3 cells is mediated by the protein 
inhibitor. 
The highly purified preparation of the catalytic 
subunit of CAMP-dependent protein kinase from 
pig brain was a kind gift of Dr S.N. Kochetkov (In- 
stitute of Molecular Biology, USSR Academy of 
Sciences, Moscow). The solution of the catalytic 
subunit (100~1, 0.4 mg/ml, 10 mM MgClz, 
20 mM Tris-HCl, pH 7.2) was added to 1 ml cell 
homogenate simultaneously with [y-“P]ATP 
(low6 M, 10’ cpm/ml) and the mixture was in- 
cubated for 1 h at 37°C. Then unlabeled ATP 
(10e4 M) was added and the incubation was con- 
tinued for 1 h. The treated homogenate, as well as 
the non-treated (control) homogenate, were used 
for DEAE-cellulose chromatography and subse- 
quent procedures (see below). 
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2.3. Isolation of 2 ‘-PDE 
The isolation of 2 ’ -PDE was carried out as in [3] 
with modifications. 
The cells (approx. 2.0 x 10s) were detached from 
the glass with standard 0.02% Versene solution, 
collected by centrifugation, resuspended in buffer 
1 (5 mM MgC12, 1 mM dithiothreitol, 10% 
glycerol, 20 mM Tris-HCl, pH 7.9, homogenized 
using a Potter homogenizer, and the homogenate 
obtained was centrifuged at 8000 x g for 6 min. 
The supernatant (10 ml, approx. 2 mg pro- 
tein/ml) was applied to a DEAE-cellulose DE-32 
(Whatman, England) column (1 x 5 cm) and 
eluted with a linear gradient (2 x 30 ml) of KC1 
(25-150 mM) based on buffer 1. The active frac- 
tions (eluted with 60-80 mM KCl) were applied to 
a phosphocellulose P-l 1 (Whatman) column (1 x 
3 cm) and eluted with the linear gradient (2 x 
20 ml) of KC1 (25-800 mM) based on buffer 2 
(1 mM dithiothreitol, 10% glycerol, 20 mM 
Tris-HCl, pH 6.7). 
Active fractions (eluted with approx. 400 mM 
KCl) were diluted with 4 vols of buffer 2 contain- 
ing 25 mM KCl, applied to a phosphocellulose 
P-l 1 column (0.3 x 1 cm) and eluted with 1 ml of 
buffer 2 containing 800 mM KC1 and 10 mM 
MgCl2 (this stage was absent in the original pro- 
cedure [3]). The material obtained was applied to 
the Sephadex G-100 column (1 x 50 cm) (instead 
of chromatography on hydroxyapatite proposed 
originally [3]) and eluted with buffer 3 (150 mM 
KCI, 5 mM MgC12, 10% glycerol, 1 mM 
dithiothreitol, 20 mM Tris-HCl, pH 7.5). The ac- 
tive fractions were collected, dialyzed against 
water and lyophilized. 
2.4. 2 ‘-PDE assay 
The 2’ -PDE activity was assayed as in [2]. 
2.5. Partial purification of 2 ‘-PDE inhibitor 
The inhibitor-containing fractions were col- 
lected after elution of proteins of the cell 
homogenate treated with protein kinase, from 
DEAE-cellulose (see above). The collected frac- 
tions were applied to a Sephadex G-100 column (1 
x JO cm) and eluted with buffer 3. Inhibitor- 
containing fractions were collected, the bovine 
serum albumin (0.3 mg/ml) was added, the protein 
was precipitated with 10% trichloroacetic acid, 
washed with acetone and then used for elec- 
trophoretic analysis. 
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To assay the inhibitor activity, the fraction of 
non-phosphorylated protein eluted from the 
DEAE-cellulose column with 60-80 mM KC1 
(fig.1) was used as the partially purified enzyme 
preparation. The samples containing lop1 of this 
enzyme preparation, 20~1 of 2’,5’-[3H]oligo(A) 
solution (approx. 2 x 10’ cpm per sample) and 
20~1 of the inhibitor fraction were incubated and 
2’ -PDE activity was assayed as usual [2]. 
Electrophoresis [4] and stain of the gels with 
AgNOr [5], were performed as described. 
3. RESULTS AND DISCUSSION 
3.1. Isolation of 2 ‘-PDE 
The treatment of the cell homogenate with the 
homogeneous catalytic subunit of CAMP- 
dependent protein kinase resulted in a 60% 
decrease in 2’-PDE activity as compared with the 
control homogenate which was incubated without 
protein kinase. 
Separation of cell homogenate proteins using the 
DEAEcellulose revealed two peaks of 2’-PDE ac- 
tivity, which were eluted at 60-80 mM (peak I) 
and 100-130 mM (peak II) KC1 (fig.1). When the 
proteins, pretreated with protein kinase, were 
separated, peak I was significantly smaller and 
shifted to the right (fig.1). This indicated that the 
decrease in 2’ -PDE activity after protein kinase 
treatment of the homogenate was associated, at 
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Fig.1. Separation of 2’-PDE from the cell homogenate 
treated (0) and not treated (0) with CAMP-dependent 
protein kinase. (- - -) KC1 concentration; bracket a 
indicates the fractions collected for 2’-PDE 
purification, bracket b the fractions collected for 
inhibitor purification. 
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Table 1 3.2. Partial purification of 2 ‘-PDE inhibitor 
Purification of 2’-PDE from NIH 3T3 cells 
Since the 2’-PDE molecules were found to be 
non-phospho~lated we supposed that tr~tment 
of the cell homogenate with the protein kinase 
resulted in activation of a protein inhibitor of 
2’-PDE, eluted from DEAE-cellulose at 
50-70 mM KCI, that caused the observed dif- 
ference in the elution profiles (fig.1) of 2’-PDE 
from the protein kinase-treated, ascompared to 
the non-treated homogenate. To check this sugges- 
tion, we carried out the 2’ -PDE assay in the 
presence of the hypothetical inhibitor (i.e., frac- 
tions 9-l 1, fig. 1) from the protein kinase-treated 
homogenate. The results demonstrated that these 
fractions contain the 2’-PDE inhibitor (table 2); 
the activity in sample 2 is higher than in sample 1 
because fractions 9-l 1 of the non-treated 
homogenate contain active 2’-PDE. 
Stage Protein 
(Q) 
General 
activity 
Wo) 
Specific 
activity 
Woo) 
Homogenate 100 100 1.0 
DE-32 24.8 167 6.7 
P-11 0.5 18 36 
G-100 0.03 16 533 
least partially, with the enzyme form which cor- 
responds to peak I. To clarify the mechanism of 
the inhibition, we carried out the isolation of this 
form of 2’-PDE, referred to here as form I. 
The result of purification of 2’-PDE from 
homogenate not treated with protein kinase is 
shown in table 1 _ The degree of 2’ -PDE purifica- 
tion was about 530, similar to the value reported 
for L-cells [3]. Electrophoresis of the preparation 
obtained showed that this represented a virtually 
homog~~us protein of 47 kDa (fig.2). A similar 
homogeneous preparation of 2’ -PDE was obtain- 
ed from the homogenate treated with protein 
kinase. However, [32P]phosphate was not detected 
in the 2’ -PDE preparation. Thus, inhibition of 
2’ -PDE caused by the homog~ate treatment with 
protein kinase did not involve direct phosphoryla- 
tion of1 2’“PDE form I. 
-wiqin 
-67KD 
-45KD 
=w 
Fii.2. Electrophoresis of the 2’-PDF, preparation. 
Positions of marker proteins (67 kDa, bovine serum 
albumin, 45 kDa, ov~bum~; 17 kDa, myoglobin; 
12 kDa, cytochrome c) are indicated. KD, kDa. 
The gel-filtration of the i~ibitor-contact 
fraction on Sephadex G-100 showed that the peak 
of inhibitory activity corresponded to 20 kDa 
(fig.3). One of the peaks of 32P radioactivity coin- 
cided with the peak of i~bito~ activity. Hence, 
there was good reason to suggest hat direct 
phosphorylation of this protein with CAMP- 
dependent protein kinase resulted in an enhance- 
ment of its inhibitory activity. 
El~trophoresis followed by autoradiography of 
the inhibitor fraction from the DEAE-cellulose 
column showed that the fraction contained three 
predominant phosphoproteins of 70, 32 and 
18 kDa. The fraction of inhibitor obtained from 
the Sephadex G-100 column contained a single 
phosphoprotein of 18 kDa (fig.4). 
Table 2 
Activity of the partially purified preparation of 2’-PDE 
in the presence of the protein inhibitor fraction 
Sample 2 ’ -PDE activity 
@pm) 
1. 2’-PDE preparation + buffer 1 
2. 2’-PDE preparation + inhibitor 
fraction from the homogenate 
not treated with protein kinase 
3. 2’-PDE preparation + inhibitor 
fraction from the homogenate 
treated with protein kinase 
5% 
870 
233 
67 
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Fig.3. Separation of the inhibitory fraction on the 
Sephadex G-100 cohnnn. The ‘*P radioactivity (0) and 
2’-PDE activity in the presence of the fractions obtained 
(0) are represented. Positions of marker proteins are 
indicated. K, kDa. 
These data allow us to suggest that the 2’ -PDE 
inhibition caused by the treatment of the cell 
homogenate with the catalytic subunit of the 
CAMP-dependent protein kinase, is not due to the 
direct phosphorylation of the enzyme itself. This 
effect appears to involve the phosphorylation of a 
1%kDa protein, the phosphoform of this protein 
being the i~bitor of 2’PDE. 
It should be noted that the data obtained o not 
exclude the possibility of some other mechanism 
for 2’-PDE inhibition by the CAMP-dependent 
protein kinase. Further investigations are 
necessary toclarify whether or not the m~ha~sm 
described is involved in the process of 2’-PDE in- 
hibition in NIH 3T3 cells which is caused by the in- 
crease in the intracellular CAMP level [2]. In- 
terestingly, however, asimilar mechanism involved 
in the regulation of the phosphatase 1 [6] was 
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Fig.4. Autoradiogram of electrophoresis of the inhibitor 
preparation before (a) and after @) purifi~tion on the 
Sephadex G-108 column. The positions of marker 
proteins are indicated. KD, kDa. 
found both in vitro and in vivo: the inhibitor of 
this enzyme (referred to as inhibitor 1) is activated 
by CAMP-dependent phosphorylation [6]. Our 
results allow us to suggest an analogous 
h~theti~ scheme of regulation for the 2’-PDF. 
REFERENCES 
Ill 
r21 
t31 
[41 
I51 
Lengyel, P. (1981) in: Interferon 3 (Gresser, I. ed.) 
pp.78-99, Academic Press, London. 
Itkes, A.V., Turpaev, K.T., Kartasheva, O.N., 
Kafiani, CA. and Severin, E.S. (1984) Mol. Cell. 
Biochem. 58, 165-171. 
Schmidt, A., Chernayovsky, Y., Shulman, L., 
Federman, P., Berissi, H. and Revel, M. (1979) 
Proc. Natl. Acad. Sci. USA 76, 4788-4792. 
Laemmli, U.K. (1970} Nature 227, 680-685. 
Oakley, B.R., Kirsch, D.R. and Morris, N.R. (1980) 
Anal. Biochem. 105, 361-366. 
Cohen, P. (1982) Nature 296, 613-620. 
68 
